LPL Financial’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $470K | Buy |
49,871
+2,067
| +4% | +$18.5K | ﹤0.01% | 5079 |
|
|
2026
Q1 | $389K | Sell |
47,804
-1,368
| -3% | -$12.4K | ﹤0.01% | 4988 |
|
|
2025
Q4 | $330K | Sell |
49,172
-6,199
| -11% | -$46.7K | ﹤0.01% | 5070 |
|
|
2025
Q3 | $480K | Sell |
55,371
-5,967
| -10% | -$46.4K | ﹤0.01% | 4664 |
|
|
2025
Q2 | $386K | Buy |
61,338
+23,467
| +62% | +$155K | ﹤0.01% | 4590 |
|
|
2025
Q1 | $243K | Sell |
37,871
-2,781
| -7% | -$23K | ﹤0.01% | 4723 |
|
|
2024
Q4 | $327K | Sell |
40,652
-4,599
| -10% | -$44.3K | ﹤0.01% | 4451 |
|
|
2024
Q3 | $572K | Buy |
45,251
+5,638
| +14% | +$72.8K | ﹤0.01% | 3882 |
|
|
2024
Q2 | $502K | Sell |
39,613
-7,096
| -15% | -$71.4K | ﹤0.01% | 3870 |
|
|
2024
Q1 | $223K | Sell |
46,709
-2,373
| -5% | -$11K | ﹤0.01% | 4429 |
|
|
2023
Q4 | $236K | Buy |
49,082
+2,973
| +6% | +$18.2K | ﹤0.01% | 4270 |
|
|
2023
Q3 | $334K | Buy |
46,109
+2,932
| +7% | +$23.4K | ﹤0.01% | 3829 |
|
|
2023
Q2 | $321K | Buy |
43,177
+9,238
| +27% | +$72.6K | ﹤0.01% | 3794 |
|
|
2023
Q1 | $235K | Buy |
33,939
+7,362
| +28% | +$67.7K | ﹤0.01% | 3924 |
|
|
2022
Q4 | $273K | Sell |
26,577
-5,191
| -16% | -$91.6K | ﹤0.01% | 3716 |
|
|
2022
Q3 | $578K | Buy |
31,768
+45
| +0.1% | +$1.95K | ﹤0.01% | 3023 |
|
|
2022
Q2 | $1.63M | Sell |
31,723
-85
| -0.3% | -$4.4K | ﹤0.01% | 2185 |
|
|
2022
Q1 | $2.34M | Sell |
31,808
-7,021
| -18% | -$626K | ﹤0.01% | 1930 |
|
|
2021
Q4 | $5.55M | Buy |
38,829
+8,048
| +26% | +$1.38M | ﹤0.01% | 1392 |
|
|
2021
Q3 | $6.38M | Buy |
30,781
+4,858
| +19% | +$1.07M | 0.01% | 1223 |
|
|
2021
Q2 | $5.5M | Buy |
25,923
+4,562
| +21% | +$836K | 0.01% | 1276 |
|
|
2021
Q1 | $3.87M | Sell |
21,361
-9,295
| -30% | -$1.85M | ﹤0.01% | 1395 |
|
|
2020
Q4 | $3.42M | Buy |
30,656
+8,017
| +35% | +$852K | ﹤0.01% | 1341 |
|
|
2020
Q3 | $2.45M | Buy |
22,639
+7,549
| +50% | +$920K | ﹤0.01% | 1343 |
|
|
2020
Q2 | $1.26M | Sell |
15,090
-80,643
| -84% | -$3.08M | ﹤0.01% | 1669 |
|
|
2020
Q1 | $1.3M | Buy |
+95,733
| New | +$810K | ﹤0.01% | 1449 |
|
|
2019
Q2 | – | Sell |
-1,317
| Closed | -$15K | – | 3321 |
|
|
2019
Q1 | $15K | Buy |
1,317
+636
| +93% | +$20.1K | ﹤0.01% | 3158 |
|
|
2018
Q4 | $25K | Buy |
681
+103
| +18% | +$3.99K | ﹤0.01% | 3030 |
|
|
2018
Q3 | $22K | Sell |
578
-193
| -25% | -$5.43K | ﹤0.01% | 3200 |
|
|
2018
Q2 | $21K | Buy |
771
+66
| +9% | +$2.23K | ﹤0.01% | 3178 |
|
|
2018
Q1 | $30K | Buy |
705
+62
| +10% | +$2.49K | ﹤0.01% | 3138 |
|
|
2017
Q4 | $16K | Sell |
643
-4,487
| -87% | -$109K | ﹤0.01% | 3005 |
|
|
2017
Q3 | $117K | Buy |
5,130
+303
| +6% | +$6.78K | ﹤0.01% | 2763 |
|
|
2017
Q2 | $111K | Buy |
4,827
+806
| +20% | +$15.8K | ﹤0.01% | 2699 |
|
|
2017
Q1 | $98K | Buy |
4,021
+2,051
| +104% | +$56.4K | ﹤0.01% | 2615 |
|
|
2016
Q4 | $50K | Buy |
1,970
+635
| +48% | +$18.5K | ﹤0.01% | 2637 |
|
|
2016
Q3 | $53K | Buy |
+1,335
| New | +$172K | ﹤0.01% | 2577 |
|
|
2016
Q2 | – | Sell |
-1,830
| Closed | -$195K | – | 2870 |
|
|
2016
Q1 | $195K | Sell |
1,830
-66
| -3% | -$7.08K | ﹤0.01% | 2798 |
|
|
2015
Q4 | $299K | Buy |
1,896
+1,095
| +137% | +$169K | ﹤0.01% | 2540 |
|
|
2015
Q3 | $114K | Sell |
801
-17
| -2% | -$3.81K | ﹤0.01% | 2633 |
|
|
2015
Q2 | $183K | Hold |
818
| – | – | ﹤0.01% | 2651 |
|
|
2015
Q1 | $136K | Sell |
818
-157
| -16% | -$25.5K | ﹤0.01% | 2639 |
|
|
2014
Q4 | $116K | Sell |
975
-68
| -7% | -$7.11K | ﹤0.01% | 2610 |
|
|
2014
Q3 | $86K | Hold |
1,043
| – | – | ﹤0.01% | 2610 |
|
|
2014
Q2 | $96K | Buy |
1,043
+130
| +14% | +$11.4K | ﹤0.01% | 2601 |
|
|
2014
Q1 | $83K | Hold |
913
| – | – | ﹤0.01% | 2564 |
|
|
2013
Q4 | $93K | Buy |
+913
| New | +$64.5K | ﹤0.01% | 2564 |
|
Other funds holding NVAX
SCM
S
LPL Financial's NVAX Position: Q2 2026 in Review
LPL Financial increased its Novavax (NVAX) stake by 4.3% in Q2 2026, buying an estimated $18.5K and bringing the position to 49,871 shares worth $470K. The position accounts for ﹤0.01% of the portfolio, ranked #5079.
LPL Financial first reported a position in NVAX in Q4 2013 and has held it in 47 quarters since. The position peaked at $6.38M in Q3 2021. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.
- LPL Financial held 49,871 shares of Novavax worth $470K as of Q2 2026.
- LPL Financial bought 2,067 Novavax shares in Q2 2026, an estimated $18.5K.
- Novavax made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #5079 holding.
- LPL Financial first reported a position in Novavax in Q4 2013 and has held it in 47 quarters since.
- LPL Financial's Novavax position peaked at $6.38M in Q3 2021.
- 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.
Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.